Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cosyntropin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracosactrin adverse reaction |
Causative agent (attribute) |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to tetracosactrin (finding) |
Causative agent (attribute) |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracosactrin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
cosyntrophine 250 microgrammes/1mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracosactrin 1mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cosyntropin 50mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cosyntropin 25mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracosactide acetate |
Is a |
False |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to tetracosactrin (finding) |
Causative agent (attribute) |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracosactide acetate |
Is modification of (attribute) |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracosactide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracosactide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracosactide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracosactide (as tetracosactide acetate) 250 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Tetracosactide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |